240 related articles for article (PubMed ID: 29914847)
1. Design and immune characterization of a novel Neisseria gonorrhoeae DNA vaccine using bacterial ghosts as vector and adjuvant.
Jiao H; Yang H; Zhao D; Chen J; Zhang Q; Liang J; Yin Y; Kong G; Li G
Vaccine; 2018 Jul; 36(30):4532-4539. PubMed ID: 29914847
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of immune responses by co-administration of bacterial ghosts-mediated Neisseria gonorrhoeae DNA vaccines.
Jiao H; Yang H; Zheng W; Zhang Q; Zhao D; Li G
J Appl Microbiol; 2021 May; 130(5):1770-1777. PubMed ID: 32770820
[TBL] [Abstract][Full Text] [Related]
3. The enhanced immune responses induced by Salmonella enteritidis ghosts loaded with Neisseria gonorrhoeae porB against Salmonella in mice.
Jiao H; Yang H; Zhao D; He L; Chen J; Li G
FEMS Microbiol Lett; 2016 Nov; 363(22):. PubMed ID: 27797865
[TBL] [Abstract][Full Text] [Related]
4. Preclinical Efficacy of a Lipooligosaccharide Peptide Mimic Candidate Gonococcal Vaccine.
Gulati S; Pennington MW; Czerwinski A; Carter D; Zheng B; Nowak NA; DeOliveira RB; Shaughnessy J; Reed GW; Ram S; Rice PA
mBio; 2019 Nov; 10(6):. PubMed ID: 31690678
[TBL] [Abstract][Full Text] [Related]
5. MetQ of Neisseria gonorrhoeae Is a Surface-Expressed Antigen That Elicits Bactericidal and Functional Blocking Antibodies.
Semchenko EA; Day CJ; Seib KL
Infect Immun; 2017 Feb; 85(2):. PubMed ID: 27895130
[TBL] [Abstract][Full Text] [Related]
6. Synthetic DNA Delivery of an Optimized and Engineered Monoclonal Antibody Provides Rapid and Prolonged Protection against Experimental Gonococcal Infection.
Parzych EM; Gulati S; Zheng B; Bah MA; Elliott STC; Chu JD; Nowak N; Reed GW; Beurskens FJ; Schuurman J; Rice PA; Weiner DB; Ram S
mBio; 2021 Mar; 12(2):. PubMed ID: 33727348
[TBL] [Abstract][Full Text] [Related]
7. Oral Immunization of Rabbits with S. enterica Typhimurium Expressing Neisseria gonorrhoeae Filamentous Phage Φ6 Induces Bactericidal Antibodies Against N. gonorrhoeae.
Piekarowicz A; Kłyż A; Majchrzak M; Stein DC
Sci Rep; 2016 Mar; 6():22549. PubMed ID: 26939573
[TBL] [Abstract][Full Text] [Related]
8. Intranasal administration of recombinant Neisseria gonorrhoeae transferrin binding proteins A and B conjugated to the cholera toxin B subunit induces systemic and vaginal antibodies in mice.
Price GA; Russell MW; Cornelissen CN
Infect Immun; 2005 Jul; 73(7):3945-53. PubMed ID: 15972481
[TBL] [Abstract][Full Text] [Related]
9. Neisseria gonorrhoeae NspA induces specific bactericidal and opsonic antibodies in mice.
Li G; Jiao H; Jiang G; Wang J; Zhu L; Xie R; Yan H; Chen H; Ji M
Clin Vaccine Immunol; 2011 Nov; 18(11):1817-22. PubMed ID: 21918113
[TBL] [Abstract][Full Text] [Related]
10. DNA immunization of mice with a plasmid encoding Neisseria gonorrhea PorB protein by intramuscular injection and epidermal particle bombardment.
Zhu W; Thomas CE; Sparling PF
Vaccine; 2004 Jan; 22(5-6):660-9. PubMed ID: 14741158
[TBL] [Abstract][Full Text] [Related]
11. Microencapsulated IL-12 Drives Genital Tract Immune Responses to Intranasal Gonococcal Outer Membrane Vesicle Vaccine and Induces Resistance to Vaginal Infection with Diverse Strains of Neisseria gonorrhoeae.
Liu Y; Hammer LA; Daamen J; Stork M; Egilmez NK; Russell MW
mSphere; 2023 Feb; 8(1):e0038822. PubMed ID: 36537786
[TBL] [Abstract][Full Text] [Related]
12. [Construction of the DNA vaccine of major outer membrane protein of Neisseria gonorrhoeae and investigation of immune effects after vaccination].
Liao F; He C; Liu HP; Song QF; Yan J
Zhonghua Yu Fang Yi Xue Za Zhi; 2006 Nov; 40(6):422-6. PubMed ID: 17313744
[TBL] [Abstract][Full Text] [Related]
13. The
Jen FE; Semchenko EA; Day CJ; Seib KL; Jennings MP
Front Immunol; 2019; 10():137. PubMed ID: 30787927
[TBL] [Abstract][Full Text] [Related]
14. Immunization against a saccharide epitope accelerates clearance of experimental gonococcal infection.
Gulati S; Zheng B; Reed GW; Su X; Cox AD; St Michael F; Stupak J; Lewis LA; Ram S; Rice PA
PLoS Pathog; 2013; 9(8):e1003559. PubMed ID: 24009500
[TBL] [Abstract][Full Text] [Related]
15. In-silico Hierarchical Approach for the Identification of Potential Universal Vaccine Candidates (PUVCs) from Neisseria gonorrhoeae.
Jain R; Sonkar SC; Chaudhry U; Bala M; Saluja D
J Theor Biol; 2016 Dec; 410():36-43. PubMed ID: 27596531
[TBL] [Abstract][Full Text] [Related]
16. Experimental vaccine induces Th1-driven immune responses and resistance to Neisseria gonorrhoeae infection in a murine model.
Liu Y; Hammer LA; Liu W; Hobbs MM; Zielke RA; Sikora AE; Jerse AE; Egilmez NK; Russell MW
Mucosal Immunol; 2017 Nov; 10(6):1594-1608. PubMed ID: 28272393
[TBL] [Abstract][Full Text] [Related]
17. Progress Toward a Gonococcal Vaccine: The Way Forward.
Russell MW; Jerse AE; Gray-Owen SD
Front Immunol; 2019; 10():2417. PubMed ID: 31681305
[TBL] [Abstract][Full Text] [Related]
18. Neisseria gonorrhoeae vaccine development: hope on the horizon?
Edwards JL; Jennings MP; Seib KL
Curr Opin Infect Dis; 2018 Jun; 31(3):246-250. PubMed ID: 29601324
[TBL] [Abstract][Full Text] [Related]
19. Complement-Dependent Serum Bactericidal Assays for Neisseria gonorrhoeae.
Gulati S; Rice PA; Ram S
Methods Mol Biol; 2019; 1997():267-280. PubMed ID: 31119629
[TBL] [Abstract][Full Text] [Related]
20. Comparison of immune responses to gonococcal PorB delivered as outer membrane vesicles, recombinant protein, or Venezuelan equine encephalitis virus replicon particles.
Zhu W; Thomas CE; Chen CJ; Van Dam CN; Johnston RE; Davis NL; Sparling PF
Infect Immun; 2005 Nov; 73(11):7558-68. PubMed ID: 16239559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
